Michael G. Rolf
AstraZeneca (Australia)(AU)AstraZeneca (Singapore)(SG)AstraZeneca (Poland)(PL)AstraZeneca (Sweden)(SE)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Cardiac electrophysiology and arrhythmias, Adenosine and Purinergic Signaling, Animal testing and alternatives, Cardiac pacing and defibrillation studies
Most-Cited Works
- → ADP is not an agonist at P2X1 receptors: evidence for separate receptors stimulated by ATP and ADP on human platelets(2000)148 cited
- → Platelet Shape Change Evoked by Selective Activation of P2X1 Purinoceptors with α,β-Methylene ATP(2001)136 cited
- → In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib(2015)108 cited
- → Time for a Fully Integrated Nonclinical–Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective(2020)94 cited
- → A study of P2X1 receptor function in murine megakaryocytes and human platelets reveals synergy with P2Y receptors(2002)77 cited
- → Effects of Enhanced P2X1 Receptor Ca2+ Influx on Functional Responses in Human Platelets(2002)46 cited